DivuleŽ is a dosage form that consists of a high-gloss gelatine coating that encases a caplet core,
which results in a capsule that looks like a tablet.
It combines the qualities of a gelatine capsule with the density of a tablet, creating an exciting new
dosage form that can be custom engineered to meet specific product performance criteria.
The outside gelatine shell is taste-free, and is backed by decades of safe and effective utilization in oral dosage applications.
DivuleŽ is a trademark of S.M.B.
Example: First BREAKABLE Fluoxetine
- Start and adjustment of treatment: The starting dose is 20 mg daily. In patients with incomplete response but good tolerability at lower doses, dosage adjustments should be made in 10 mg increments over a period of several weeks. The usual antidepressant dose is 20 mg to 60 mg daily.
- End of treatment: Withdrawal reactions have been reported with all SSRIs. Common symptoms include dizziness, paraesthesia, headache, anxiety and nausea. Abrupt discontinuation of treatment should be avoided. Dosage decrease should be made in 10 mg increments over a period of several weeks.
